AGLVSBBOT• 28 Days (Normalized)
AGL vs BBOT (agilon health inc. vs BridgeBio Oncology Therapeutics Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AGL Performance $84.14
-4.93%
agilon health inc.
Normalized Baseline0.00%
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin AGL LEADS
+51.75 pts
AGL outperforming by 51.75 percentage points
AGLBBOT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AGL BBOT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AGL Price | AGL Gain (%) | BBOT Price | BBOT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $84.14 | -4.93% | $3.89 | -56.68% | +51.75% |
| Oct 01, 2026 | $82.28 | -7.03% | $- | - | |
| Sep 30, 2026 | $79.59 | -10.07% | $4.10 | -54.34% | +44.27% |
| Sep 29, 2026 | $78.15 | -11.69% | $3.92 | -56.35% | +44.66% |
| Sep 28, 2026 | $79.53 | -10.14% | $3.81 | -57.57% | +47.43% |
| Sep 25, 2026 | $80.73 | -8.78% | $3.95 | -56.01% | +47.23% |
| Sep 24, 2026 | $75.83 | -14.32% | $3.99 | -55.57% | +41.25% |
| Sep 23, 2026 | $84.56 | -4.45% | $4.16 | -53.67% | +49.22% |
| Sep 22, 2026 | $86.84 | -1.88% | $4.66 | -48.11% | +46.23% |
| Sep 21, 2026 | $88.03 | -0.53% | $4.66 | -48.11% | +47.58% |
| Sep 18, 2026 | $89.16 | +0.75% | $4.77 | -46.88% | +47.63% |
| Sep 17, 2026 | $89.17 | +0.76% | $4.89 | -45.55% | +46.31% |
| Sep 16, 2026 | $89.66 | +1.31% | $4.76 | -46.99% | +48.30% |
| Sep 15, 2026 | $92.12 | +4.09% | $4.88 | -45.66% | +49.75% |
| Sep 14, 2026 | $92.38 | +4.38% | $5.05 | -43.76% | +48.14% |
Page 1 of 2